HWAM
WST icon

Hennion & Walsh Asset Management’s West Pharmaceutical WST Stock Holding History

Hennion & Walsh Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$969K Sell
2,699
-295
-10% -$90.2K 0.03% 568
2026
Q1 		$750K Sell
2,994
-2,268
-43% -$564K 0.03% 581
2025
Q4 		$1.45M Sell
5,262
-222
-4% -$60.7K 0.05% 424
2025
Q3 		$1.44M Sell
5,484
-22
-0.4% -$5.35K 0.05% 420
2025
Q2 		$1.2M Buy
5,506
+480
+10% +$103K 0.05% 451
2025
Q1 		$1.13M Buy
5,026
+1,117
+29% +$308K 0.05% 448
2024
Q4 		$1.28M Buy
3,909
+580
+17% +$183K 0.06% 405
2024
Q3 		$999K Buy
3,329
+1,659
+99% +$508K 0.05% 452
2024
Q2 		$550K Buy
1,670
+664
+66% +$235K 0.03% 567
2024
Q1 		$398K Buy
+1,006
New +$372K 0.02% 625
2022
Q2 		– Sell
-730
Closed -$300K – 803
2022
Q1 		$300K Sell
730
-7
-0.9% -$2.74K 0.02% 656
2021
Q4 		$346K Sell
737
-13
-2% -$5.6K 0.02% 619
2021
Q3 		$318K Sell
750
-3
-0.4% -$1.26K 0.02% 623
2021
Q2 		$270K Sell
753
-15
-2% -$4.96K 0.01% 643
2021
Q1 		$216K Buy
+768
New +$220K 0.01% 658

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Hennion & Walsh Asset Management's WST Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its West Pharmaceutical (WST) stake by 9.9% in Q2 2026, selling an estimated $90.2K and leaving 2,699 shares worth $969K. The position accounts for 0.03% of the portfolio, ranked #568.

Hennion & Walsh Asset Management first reported a position in WST in Q1 2021 and has held it in 15 quarters since. The position peaked at $1.45M in Q4 2025. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Hennion & Walsh Asset Management held 2,699 shares of West Pharmaceutical worth $969K as of Q2 2026.
  • Hennion & Walsh Asset Management sold 295 West Pharmaceutical shares in Q2 2026, an estimated $90.2K.
  • West Pharmaceutical made up 0.03% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #568 holding.
  • Hennion & Walsh Asset Management first reported a position in West Pharmaceutical in Q1 2021 and has held it in 15 quarters since.
  • Hennion & Walsh Asset Management's West Pharmaceutical position peaked at $1.45M in Q4 2025.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.